MIF and familial pancreatic carcinoma: A recent study (Suresh et al., 2019) found that recombinant MIF treatment significantly enhanced tumor growth via promoting angiogenesis in a hamster pancreatic cancer model induced by subcutaneous inoculation with HapT1 cells.